Healthcare / Medical DistributionShenzhen
$2.92
-0.02 (-0.68%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $-13.1M · quality 33.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
23/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.4B
P/E
292.0x
↑EV/EBITDA
15.4x
↑ROE
0.3%
↑Gross Margin
10.6%
↓Debt/Equity
0.87
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-16.0%
FCF CAGR
—
FCF margin
-0.2%
FCF / Net income
-0.81x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $7.30B · net income $16.1M · FCF $-13.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.30B | $7.30B | $7.97B | $8.03B | $12.31B |
| Net Income | $16.1M | $16.1M | $12.3M | $20.3M | $-1.83B |
| EBITDA | $360.7M | $360.7M | $423.8M | $388.0M | $-1.05B |
| EPS | 0.01 | 0.01 | 0.01 | 0.01 | -1.24 |
| Gross Margin | 10.6% | 10.6% | 11.0% | 10.3% | 13.6% |
| Operating Margin | 0.9% | 0.9% | 0.8% | -0.8% | 0.5% |
| Net Margin | 0.2% | 0.2% | 0.2% | 0.3% | -14.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.87 | 0.87 | 1.19 | 1.25 | 0.72 |
| Current Ratio | 1.10 | 1.10 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-13.1M | $-13.1M | $49.2M | $-215.9M | $352.1M |
| Returns | |||||
| ROE | 0.3% | 0.3% | 0.2% | 0.4% | -33.9% |
| Valuation | |||||
| P/E | 292.00 | 292.00 | 277.00 | 237.78 | — |
| EV/EBITDA | 15.40 | 15.40 | 11.81 | 17.00 | — |
| P/B | 0.89 | 0.89 | 0.61 | 0.89 | 1.14 |
| Growth & Yield | |||||
| Revenue Growth | -8.4% | -8.4% | -0.8% | -34.7% | — |
| EPS Growth | 0.0% | 0.0% | -25.9% | 101.1% | — |
| Dividend Yield | 0.4% | 0.4% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
195.9%
EPS terminal req.
$0.26
Spread vs growth
-195.9%
5Y implied EPS CAGR
99.2%
EPS terminal req.
$0.31
Spread vs growth
-99.2%
10Y implied EPS CAGR
48.0%
EPS terminal req.
$0.50
Spread vs growth
-48.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-1.6%
Start / end P/E
298.0x → 292.0x
EPS bridge
0.01 → 0.01
Residual
-0.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.